Close Menu

NEW YORK (360Dx) — CareFirst BlueCross BlueShield has struck a deal to evaluate the clinical impact of Exagen Diagnostics' Avise Lupus test for the differential diagnosis of systemic lupus erythematosus (SLE), the companies announced today.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.